Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.1M Sell
3,863
-611
-14% -$837K 1.85% 16
2025
Q4
$4.79M Buy
4,474
+756
+20% +$789K 1.76% 17
2025
Q3
$3.6M Sell
3,718
-1,352
-27% -$1.06M 1.41% 20
2025
Q2
$4.06M Buy
5,070
+566
+13% +$406K 1.62% 19
2025
Q1
$2.98M Buy
4,504
+255
+6% +$186K 1.41% 21
2024
Q4
$2.94M Buy
4,249
+852
+25% +$612K 1.39% 19
2024
Q3
$2.83M Buy
3,397
+122
+4% +$109K 1.34% 18
2024
Q2
$3.35M Sell
3,275
-145
-4% -$139K 1.8% 15
2024
Q1
$3.32M Buy
3,420
+36
+1% +$31.9K 2.04% 14
2023
Q4
$2.56M Buy
3,384
+108
+3% +$71.3K 1.87% 14
2023
Q3
$1.93M Buy
3,276
+117
+4% +$77.7K 1.55% 17
2023
Q2
$2.29M Sell
3,159
-292
-8% -$199K 1.76% 15
2023
Q1
$2.35M Sell
3,451
-351
-9% -$225K 1.96% 13
2022
Q4
$2.08M Buy
+3,802
New +$1.99M 1.92% 13

Other funds holding ASML

Ted Buchan & Co's ASML Position: Q1 2026 in Review

Ted Buchan & Co reduced its ASML (ASML) stake by 14% in Q1 2026, selling an estimated $837K and leaving 3,863 shares worth $5.1M. The position accounts for 1.85% of the portfolio, ranked #16.

Ted Buchan & Co first reported a position in ASML in Q4 2022 and has held it in 14 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Ted Buchan & Co held 3,863 shares of ASML worth $5.1M as of Q1 2026.
  • Ted Buchan & Co sold 611 ASML shares in Q1 2026, an estimated $837K.
  • ASML made up 1.85% of Ted Buchan & Co's portfolio in Q1 2026, its #16 holding.
  • Ted Buchan & Co first reported a position in ASML in Q4 2022 and has held it in 14 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Ted Buchan & Co's 13F filing for Q1 2026, filed 14 May 2026.